19-3594847-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001060.6(TBXA2R):c.*841A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,536,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000094 ( 0 hom. )
Consequence
TBXA2R
NM_001060.6 3_prime_UTR
NM_001060.6 3_prime_UTR
Scores
2
14
Clinical Significance
Conservation
PhyloP100: -0.0240
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.08223149).
BS2
High AC in GnomAd4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.*841A>G | 3_prime_UTR_variant | 3/3 | ENST00000375190.10 | NP_001051.1 | ||
TBXA2R | NM_201636.3 | c.1213A>G | p.Arg405Gly | missense_variant | 4/4 | NP_963998.2 | ||
TBXA2R | XM_011528214.3 | c.*841A>G | 3_prime_UTR_variant | 4/4 | XP_011526516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.*841A>G | 3_prime_UTR_variant | 3/3 | 1 | NM_001060.6 | ENSP00000364336 | P1 | ||
TBXA2R | ENST00000589966.1 | c.*704A>G | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000468145 | ||||
TBXA2R | ENST00000411851.3 | c.1213A>G | p.Arg405Gly | missense_variant | 4/4 | 2 | ENSP00000393333 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152264Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152264
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000624 AC: 9AN: 144146Hom.: 0 AF XY: 0.0000519 AC XY: 4AN XY: 77022
GnomAD3 exomes
AF:
AC:
9
AN:
144146
Hom.:
AF XY:
AC XY:
4
AN XY:
77022
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000939 AC: 13AN: 1384438Hom.: 0 Cov.: 30 AF XY: 0.00000439 AC XY: 3AN XY: 683118
GnomAD4 exome
AF:
AC:
13
AN:
1384438
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
683118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152382Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74520
GnomAD4 genome
AF:
AC:
6
AN:
152382
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74520
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 07, 2023 | Variant summary: TBXA2R c.*841A>G is located in the untranslated mRNA region downstream of the termination codon. The variant allele was found at a frequency of 6.2e-05 in 144146 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.*841A>G in individuals affected with Bleeding Diathesis Due To Thromboxane Synthesis Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. This variant is also observed as c.1213A>G (p.Arg405Gly) in NM_001060.6. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.0275);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at